Morphine Dosing for Severe Chest Pain in Acute MI with Renal Impairment

Initial Dosing Protocol

The American College of Cardiology recommends administering morphine sulfate 2-4 mg IV initially, repeated every 5 minutes as needed for pain relief, with dose reduction of 30-50% in elderly patients and careful monitoring for respiratory depression and hypotension 1, 2
Repeat doses of 2 mg can be given at 5-minute intervals until adequate pain relief is achieved, with some patients requiring cumulative doses of 25-30 mg before pain is adequately controlled 1, 2
The European Society of Cardiology recommends 4-8 mg for more severe pain, though this represents the higher end of dosing 2

Reduce starting doses by 30-50% in elderly patients (>70 years), who often have some degree of renal impairment 4

Monitor respiratory rate, oxygen saturation, blood pressure, and level of consciousness continuously for the first 20 minutes after each dose, then hourly for at least 2 hours, and notify physician if respiratory rate falls below 8 breaths/minute, heart rate <60 or >110, or systolic blood pressure <90 mmHg 1, 4
Have naloxone 0.4 mg IV immediately available; administer at 3-minute intervals up to 3 doses for respiratory depression 1, 5, 6
Morphine-induced hypotension typically occurs in volume-depleted patients and usually responds to supine positioning, IV fluids, or atropine if bradycardia is present 1, 5, 6

Avoid concomitant IV nitroglycerin in patients with severe unremitting pain to prevent excessive hypotension 1, 2
Respiratory depression is the most serious complication but occurs rarely in MI patients due to sympathetic discharge from pain 1, 5, 6
Nausea and vomiting occur in approximately 20% of patients and can be managed with antiemetics 2, 5

Recent observational data suggest morphine may be associated with increased mortality (adjusted OR 1.41), though this remains subject to selection bias and has not been confirmed in randomized trials 5, 6
This concern led to downgrading morphine from Class I to Class IIa recommendation in UA/NSTEMI guidelines 5, 6

Instruct patients to report pain immediately using a numeric scale (1-10) to guide dosing decisions, and pain relief should be prompt at diagnosis and not delayed to evaluate anti-ischemic therapy 1, 2, 3